miR-22 inhibits tumor growth and metastasis by targeting ATP citrate lyase: evidence in osteosarcoma, prostate cancer, cervical cancer and lung cancer

Mei Xin(Chengdu University), Gang Huang(Shanghai Jiao Tong University)
Oncotarget
June 14, 2016
Cited by 173


Related Papers